Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

43°
- Bishop, CA (93514)
  Today
  
  A mix of clouds and sun. High around 70F. Winds SSE at 10 to 20 mph..
  
  Tonight
  
  Cloudy. Low 37F. Winds NNE at 5 to 10 mph.
  
  Updated: December 22, 2025 @ 6:15 am
- Full Forecast

Site search

Home
News
Sports
Obituaries
e-Edition
Special Sections
Classifieds
- Place an ad
Archives

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Zymeworks Inc. - Common Stock (NQ:ZYME)

27.02 -0.21 (-0.77%)

Streaming Delayed Price Updated: 9:41 AM EST, Dec 22, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Zymeworks Inc. - Common Stock

< Previous 1 2 3 4 Next >

Which stocks are moving after the closing bell on Tuesday? ↗

December 02, 2025

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Via Chartmill

Zymeworks Announces Participation in Upcoming Conferences

December 02, 2025

From Zymeworks Inc.

Via GlobeNewswire

Zymeworks Announces Participation in Upcoming Investor Conferences

November 24, 2025

From Zymeworks Inc.

Via GlobeNewswire

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

5 Analysts Have This To Say About Zymeworks ↗

October 24, 2025

Via Benzinga

Zymeworks Stock Sees Surge In Retail Chatter After Royalty Pivot, Cancer Trial Win Sparks Target Price Hikes ↗

November 24, 2025

Strong new Phase 3 Ziihera data boosted confidence in upcoming regulatory milestones.

Via Stocktwits

Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033

November 18, 2025

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:RXRX),(NASDAQ:NTLA),(NASDAQ:ZYME),(NYSE:ANVS) EQNX::TICKER_END

Via FinancialNewsMedia

Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033

November 18, 2025

From MarketNewsUpdates.com

Via GlobeNewswire

Alphabet To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

November 18, 2025

Via Benzinga

Zymeworks Appoints Scott Platshon as Acting Chief Investment Officer

November 18, 2025

From Zymeworks Inc.

Via GlobeNewswire

Zymeworks Announces Strategic Initiative to Optimize Value of Licensed Products by Building a Diversified Portfolio of Revenue-Generating Assets

November 18, 2025

From Zymeworks Inc.

Via GlobeNewswire

Let's take a look at the stocks that are in motion in today's session. ↗

November 17, 2025

Looking for insights into the US markets one hour before the close of the markets on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

Zymeworks, Jazz Pharmaceuticals Stocks Climb On Robust Gastroesophageal Trial Outcomes And Upcoming Regulatory Plans ↗

November 17, 2025

Zymeworks rises after Ziihera shows significant PFS and OS benefits in a Phase 3 trial, supporting plans for regulatory filings and guideline submissions.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 17, 2025

Via Benzinga

Jazz Pharmaceuticals, Sigma Lithium, Zymeworks And Other Big Stocks Moving Higher On Monday ↗

November 17, 2025

Via Benzinga

The market is filled with gapping stocks in Monday's session. ↗

November 17, 2025

In today's session, there are notable price gaps in the US markets on Monday. Take a closer look at the stocks that are gap up and gap down.

Via Chartmill

Mixed Signals Point to Cautious Open for U.S. Markets as Tech Shines Amidst Economic Data Delays

November 17, 2025

U.S. equity futures are signaling a mixed but largely cautious start to the trading day on November 17, 2025, with technology stocks once again taking the lead, while broader indices like the Dow Jones...

Via MarketMinute

Jazz, Zymeworks Catapult On Their 'Sweeping Success' In Gastric Cancer ↗

November 17, 2025

Shares of Jazz Pharmaceuticals and Zymeworks catapulted Monday on positive test results for a gastric cancer drug.

Via Investor's Business Daily

These stocks are moving in today's pre-market session ↗

November 17, 2025

Before the opening bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 17, 2025

Via Benzinga

Zymeworks Announces Positive HERIZON-GEA-01 Phase 3 Results Supporting Ziihera® (zanidatamab-hrii) as HER2-Targeted Agent-of-Choice and New Standard of Care in First-Line HER2-Positive Locally Advanced or Metastatic Gastroesophageal Adenocarcinoma

November 17, 2025

From Zymeworks Inc.

Via GlobeNewswire

Zymeworks Inc (NASDAQ:ZYME) Shows Strong Technical and Fundamental Momentum ↗

November 11, 2025

Discover how Zymeworks (ZYME) combines strong technical trends with accelerating earnings and sales growth, making it a top high-growth stock candidate.

Via Chartmill

Zymeworks Inc (NASDAQ:ZYME) Reports Mixed Q3 2025 Results with Narrower Loss but Revenue Miss ↗

November 06, 2025

Zymeworks Q3 2025: Narrower-than-expected loss and strong cash position, though revenue missed estimates. Clinical pipeline advances with promising data.

Via Chartmill

Zymeworks Provides Corporate Update and Reports Third Quarter 2025 Financial Results

November 06, 2025

From Zymeworks Inc.

Via GlobeNewswire

Zymeworks Announces Participation in Upcoming Investor Conferences

October 28, 2025

From Zymeworks Inc.

Via GlobeNewswire

Zymeworks Presents Initial Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺ at AACR-NCI-EORTC Conference

October 23, 2025

From Zymeworks Inc.

Via GlobeNewswire

Zymeworks to Report Third Quarter 2025 Financial Results and Host Conference Call on November 6, 2025

October 16, 2025

From Zymeworks Inc.

Via GlobeNewswire

Broadcom To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

October 14, 2025

Via Benzinga

This RPM International Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗

October 14, 2025

Via Benzinga

Zymeworks to Present Clinical Data from the Phase 1 trial of ZW191, an Antibody-Drug Conjugate Targeting Folate Receptor-⍺, at AACR-NCI-EORTC International Conference

October 13, 2025

From Zymeworks Inc.

Via GlobeNewswire

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Local Events
Obituaries
Multimedia
Online Features
Announcements

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

Contact Information

InyoRegister.com
407 W. Line St. #8
Bishop, CA 93514
Phone: 760-873-3535

Advertising

Retail Sales: egalanski@inyoregister.com
Classified Sales: classy@inyoregister.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Bishop, CA (93514)

Today

Tonight

Zymeworks Inc. - Common Stock (NQ:ZYME)

All News about Zymeworks Inc. - Common Stock

Sections

Services

Contact Information